Prosecution Insights
Last updated: April 19, 2026

Examiner: STRIEGEL, THEODORE CHARLES

Tech Center 1600 • Art Units: 1671 1685

This examiner grants 14% of resolved cases

Performance Statistics

13.7%
Allow Rate
-46.3% vs TC avg
84
Total Applications
+24.8%
Interview Lift
1634
Avg Prosecution Days
Based on 51 resolved cases, 2023–2026

Rejection Statute Breakdown

28.8%
§101 Eligibility
6.9%
§102 Novelty
30.1%
§103 Obviousness
22.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17476398 METHODS AND SYSTEMS FOR BARCODE ERROR CORRECTION Final Rejection 10x Genomics, Inc.
16951864 PIPELINE FOR SPATIAL ANALYSIS OF ANALYTES Non-Final OA 10X Genomics, Inc.
17091484 Accurate And Robust Information-Deconvolution From Bulk Tissue Transcriptomes Final Rejection Regeneron Pharmaceuticals, Inc.
16963093 BIOMARKERS AND CLASSIFICATION ALGORITHMS FOR CHRONIC KIDNEY DISEASE IN CATS Non-Final OA MARS, INCORPORATED
17197900 WAVEFORM-BASED HEMODYNAMIC INSTABILITY WARNING Final Rejection KONINKLIJKE PHILIPS N.V.
17452040 MACHINE LEARNING PLATFORM FOR GENERATING RISK MODELS Final Rejection 23andMe, Inc.
17560274 TECHNOLOGIES FOR NUCLEOTIDE SEQUENCE SCREENING Non-Final OA Battelle Memorial Institute
17273467 Method or System for Identification of a Causative Mutation Causing a Phenotype of Interest in a Test Sample Non-Final OA Oxford University Innovation Limited
18753672 Machine Learning Disease Prediction and Treatment Prioritization Non-Final OA AMPEL BioSolutions, LLC
16679109 MACHINE LEARNING DISEASE PREDICTION AND TREATMENT PRIORITIZATION Non-Final OA AMPEL BioSolutions, LLC
18164446 MULTI-OMIC ASSESSMENT Non-Final OA PrognomIQ, Inc.
16825877 METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS Non-Final OA Sequenom, Inc.
17059060 COMPUTATIONAL PROTEIN DESIGN USING TERTIARY OR QUATERNARY STRUCTURAL MOTIFS Non-Final OA Trustees of Dartmouth College
17829082 UNIVERSAL PLATFORM FOR CAR THERAPY TARGETING A NOVEL ANTIGENIC SIGNATURE OF CANCER Final Rejection GAVISH-GALILEE BIO APPLICATIONS LTD.
17272885 NETWORK METHODS FOR NEURODEGENERATIVE DISEASES Final Rejection Genting TauRx Diagnostic Centre SDN BHD
17271665 METHODS FOR RANKING AND/OR SELECTING TUMOR-SPECIFIC NEOANTIGENS Non-Final OA CECAVA GMBH & Co. KG
16761663 SYSTEM AND METHODS FOR GRAPHIC ENCODING OF MACROMOLECULES FOR EFFICIENT HIGH-THROUGHPUT ANALYSIS Non-Final OA STC.UNM.
16629247 METHODS FOR ANALYZING METABOLIC DRIFT IN A SUBJECT Final Rejection Arnaud LECLEVE

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month